Prolonged apnoea following E.C.T. modified by suxethonium (brevidil E).
D001049:Apnea / Q000209:etiology*; D003295:Convulsive Therapy; D004565:Electroconvulsive Therapy; D006801:Humans; D009125:Muscle Relaxants, Central / Q000009:adverse effects*; D013390:Succinylcholine / Q000031:analogs & derivatives
D009125:Muscle Relaxants, Central; D013390:Succinylcholine; C013696:suxethonium
APNEA/etiology and pathogenesis; MUSCLE RELAXANTS/injurious effects; SHOCK THERAPY, ELECTRIC